| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 105,955 | 101,837 | 98,260 | 93,872 | | Cost of Revenue | 36,024 | 34,465 | 31,879 | 30,410 | | | Gross Profit | 69,931 | 67,372 | 66,381 | 63,462 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 58,803 | 57,192 | 55,461 | 51,566 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 13,176 | 12,028 | 11,529 | 12,698 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,048) | (1,848) | (609) | (802) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (65) | 37 | 16 | 1,708 | | Earnings Before Interest And Taxes | (2,113) | (1,811) | (593) | 906 | | Interest Expense | 41 | 21 | 89 | 56 | | Income Before Tax | (2,154) | (1,832) | (682) | 850 | | Income Tax Expense | (1,156) | 374 | (741) | 317 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (998) | (2,206) | 59 | 533 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (998) | (2,206) | 59 | 533 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($998) | ($2,206) | $59 | $533 |
|
0.51% Nasdaq 
Income Statement
